IA
GILD icon

Icon Advisers’s Gilead Sciences GILD Stock Holding History

Icon Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-31,500
Closed -$2.14M – 395
2017
Q1 		$2.14M Sell
31,500
-36,300
-54% -$2.55M 0.15% 187
2016
Q4 		$4.86M Hold
67,800
– – 0.33% 103
2016
Q3 		$5.36M Buy
+67,800
New +$5.51M 0.36% 100
2016
Q1 		– Sell
-85,512
Closed -$8.65M – 353
2015
Q4 		$8.65M Hold
85,512
– – 0.59% 57
2015
Q3 		$8.4M Buy
85,512
+1,000
+1% +$111K 0.58% 55
2015
Q2 		$9.89M Sell
84,512
-105,700
-56% -$11.5M 0.62% 55
2015
Q1 		$18.7M Buy
190,212
+11,800
+7% +$1.2M 1.09% 21
2014
Q4 		$16.8M Buy
178,412
+80,900
+83% +$8.37M 1% 23
2014
Q3 		$10.4M Sell
97,512
-22,470
-19% -$2.2M 0.6% 52
2014
Q2 		$9.95M Sell
119,982
-9,000
-7% -$701K 0.62% 41
2014
Q1 		$9.14M Buy
128,982
+46,600
+57% +$3.65M 0.65% 37
2013
Q4 		$6.19M Sell
82,382
-8,000
-9% -$557K 0.45% 57
2013
Q3 		$5.68M Sell
90,382
-16,700
-16% -$998K 0.43% 55
2013
Q2 		$5.49M Buy
+107,082
New +$5.58M 0.42% 55

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Icon Advisers's GILD Position: Q2 2017 in Review

Icon Advisers sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 31,500 shares — an estimated $2.14M sold.

Icon Advisers first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $18.7M in Q1 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Icon Advisers reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Icon Advisers sold 31,500 Gilead Sciences shares in Q2 2017, an estimated $2.14M.
  • Icon Advisers first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
  • Icon Advisers's Gilead Sciences position peaked at $18.7M in Q1 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Icon Advisers's 13F filing for Q2 2017, filed 10 Aug 2017.